These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10769058)

  • 21. T cell responses to the human papillomavirus type 16 E7 protein in mice of different haplotypes.
    Shepherd PS; Tran TT; Rowe AJ; Cridland JC; Comerford SA; Chapman MG; Rayfield LS
    J Gen Virol; 1992 May; 73 ( Pt 5)():1269-74. PubMed ID: 1316944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins.
    Davidson EJ; Boswell CM; Sehr P; Pawlita M; Tomlinson AE; McVey RJ; Dobson J; Roberts JS; Hickling J; Kitchener HC; Stern PL
    Cancer Res; 2003 Sep; 63(18):6032-41. PubMed ID: 14522932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chimeric hepatitis B core antigen particles containing B- and Th-epitopes of human papillomavirus type 16 E7 protein induce specific antibody and T-helper responses in immunised mice.
    Tindle RW; Herd K; Londoño P; Fernando GJ; Chatfield SN; Malcolm K; Dougan G
    Virology; 1994 May; 200(2):547-57. PubMed ID: 7513919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunization with adenoviral vectors carrying recombinant IL-12 and E7 enhanced the antitumor immunity to human papillomavirus 16-associated tumor.
    Jin HS; Park EK; Lee JM; NamKoong SE; Kim DG; Lee YJ; Jun HJ; Han BD; Bae SM; Ahn WS
    Gynecol Oncol; 2005 May; 97(2):559-67. PubMed ID: 15863160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. L1-specific protection from tumor challenge elicited by HPV16 virus-like particles.
    De Bruijn ML; Greenstone HL; Vermeulen H; Melief CJ; Lowy DR; Schiller JT; Kast WM
    Virology; 1998 Oct; 250(2):371-6. PubMed ID: 9792847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of HPV DNA vaccines employing intracellular targeting strategies.
    Kim JW; Hung CF; Juang J; He L; Kim TW; Armstrong DK; Pai SI; Chen PJ; Lin CT; Boyd DA; Wu TC
    Gene Ther; 2004 Jun; 11(12):1011-8. PubMed ID: 14985791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene gun-mediated DNA vaccination induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the liver and lungs.
    Chen CH; Ji H; Suh KW; Choti MA; Pardoll DM; Wu TC
    Gene Ther; 1999 Dec; 6(12):1972-81. PubMed ID: 10637448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells.
    Matesic D; Valujskikh A; Pearlman E; Higgins AW; Gilliam AC; Heeger PS
    J Immunol; 1998 Nov; 161(10):5236-44. PubMed ID: 9820495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Murine lymph node antigen presenting cells are the main source of interleukin-6 in the initiation of delayed-type hypersensitivity.
    Ulrich P; Vohr HW
    Eur Cytokine Netw; 1996 Sep; 7(3):401-7. PubMed ID: 8954184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunization strategy against cervical cancer involving an alphavirus vector expressing high levels of a stable fusion protein of human papillomavirus 16 E6 and E7.
    Daemen T; Regts J; Holtrop M; Wilschut J
    Gene Ther; 2002 Jan; 9(2):85-94. PubMed ID: 11857066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Th2-type CD4+ cells neither enhance nor suppress antitumor CTL activity in a mouse tumor model.
    Fernando GJ; Stewart TJ; Tindle RW; Frazer IH
    J Immunol; 1998 Sep; 161(5):2421-7. PubMed ID: 9725239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. E7 oncoprotein of human papillomavirus type 16 expressed constitutively in the epidermis has no effect on E7-specific B- or Th-repertoires or on the immune response induced or sustained after immunization with E7 protein.
    Herd K; Fernando GJ; Dunn LA; Frazer IH; Lambert P; Tindle RW
    Virology; 1997 Apr; 231(1):155-65. PubMed ID: 9143315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional oral tolerance in transgenic 2C mice.
    Margenthaler JA; Flye MW
    Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-mediated immune responses to E7 peptides of human papillomavirus (HPV) type 16 are dependent on the HPV type infecting the cervix whereas serological reactivity is not type-specific.
    Kadish AS; Romney SL; Ledwidge R; Tindle R; Fernando GJ; Zee SY; Van Ranst MA; Burk RD
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2277-84. PubMed ID: 8077925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.
    Utermöhlen O; Schulze-Garg C; Warnecke G; Gugel R; Löhler J; Deppert W
    J Virol; 2001 Nov; 75(22):10593-602. PubMed ID: 11602701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent display of human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as witness of previous viral encounter.
    Welters MJ; de Jong A; van den Eeden SJ; van der Hulst JM; Kwappenberg KM; Hassane S; Franken KL; Drijfhout JW; Fleuren GJ; Kenter G; Melief CJ; Offringa R; van der Burg SH
    Cancer Res; 2003 Feb; 63(3):636-41. PubMed ID: 12566307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential strategies utilised by papillomavirus to evade host immunity.
    Frazer IH; Thomas R; Zhou J; Leggatt GR; Dunn L; McMillan N; Tindle RW; Filgueira L; Manders P; Barnard P; Sharkey M
    Immunol Rev; 1999 Apr; 168():131-42. PubMed ID: 10399070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of rat CD4+ proliferative and mouse CD8+ cytotoxic T-cell lines specific for human papillomavirus type 16 antigens.
    Bagot M; Charue D; Cerni C; Revuz J; Meneguzzi G
    Res Virol; 1996; 147(5):301-11. PubMed ID: 8880999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NKT cells inhibit antigen-specific effector CD8 T cell induction to skin viral proteins.
    Mattarollo SR; Yong M; Gosmann C; Choyce A; Chan D; Leggatt GR; Frazer IH
    J Immunol; 2011 Aug; 187(4):1601-8. PubMed ID: 21742969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerance or immunity to a tumor antigen expressed in somatic cells can be determined by systemic proinflammatory signals at the time of first antigen exposure.
    Frazer IH; De Kluyver R; Leggatt GR; Guo HY; Dunn L; White O; Harris C; Liem A; Lambert P
    J Immunol; 2001 Dec; 167(11):6180-7. PubMed ID: 11714778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.